PhageLine #31: Bacteriophage-Mediated Vitamin B12 Release

PhageLine #30: Bacteriophage-Fusidic Acid Synergy In An Ex Vivo Dermis Model

PhageLine #29: Phage Therapy With Artificial Antigen-­Directed Immune Labeling

PhageLine #28: A Beginner’s Guide to Viral Diversity

PhageLine #27: Anti-Restriction Phage Proteins

PhageLine #26: Selection and Cost of Bacteriophage Resistance

PhageLine #25: Efficacy of Sequential Phage-Colistin Therapy

PhageLine #24: A Phage Hydrogel for Burn Wounds

PhageLine #23: Bacteriophage Vaccine Against PEDV

PhageLine #22: Phage-Antibiotic Synergy

PhageLine #21: Microplastics and Bacteriophages

PhageLine #20: Is SARS-CoV-2 a Bacteriophage?

PhageLine #19: Targeted Discovery by Co-Culture (Phage DisCo)

PhageLine #18: A Highly Robust Acinetobacter baumannii Phage

PhageLine #17: Personalized Phage Therapy in Cystic Fibrosis Infections

PhageLine #16: Bacteriophage Interactions

PhageLine #15: Identifying Phage Depolymerases

PhageLine #14: Phage Recognition and Immunogenicity in Humans

PhageLine #13: Optimizing Bacteriophage Engineering Through an Accelerated Evolution Platform

PhageLine #12: Biofilm Models for Phage Therapy of Diabetic Foot Ulcers